Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

Today, Seraphina Therapeutics, the pioneer in healthspan-extending nutrient research, announced an addition to its leadership ...

Prebys Foundation is excited to announce the launch of the Prebys Ventures Impact Fund (Prebys Ventures), a $50 million impact investment fund dedicated to driving growth and technological advancement ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25. If approved, FILSPARI could be the first and only approv ...

Diane Simeone, MD, credits her fascination with human biology and dedication as a student athlete with instilling in her a ...

GAINESVILLE, Fla. - Cyclo Therapeutics, Inc. (NASDAQ:CYTH), a clinical-stage biotechnology firm with a market capitalization of $22.15 million, announced positive data from a sub-study of its pivotal ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage biopharmaceutical drug development company focused ...